Clinical Trial Update: Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports that tight glycemic control increases cardiac stem cells during acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Myocardial Infarction, Oxidative Stress | Phase 4 | Status: COMPLETED